Postmenopausal women have a higher rate of osteoporosis and fractures than older men. Postmenopausal women have decreased ... The term "established osteoporosis" is used when a broken bone due to osteoporosis has occurred. Osteoporosis is a part of ... "Postmenopausal osteoporosis". Trans. Assoc. Am. Physicians. 55: 298-305. Hirata K, Morimoto I (1994). "Vertebral Osteoporosis ... "European guidance for the diagnosis and management of osteoporosis in postmenopausal women". Osteoporosis international: a ...

Type I refers to postmenopausal osteoporosis and is caused by the deficiency of estrogen. While senile osteoporosis is ... it can still be a contributing factor to primary osteoporosis. Secondary osteoporosis can be present in pre- and post- ... Postmenopausal Osteoporosis". The New England Journal of Medicine. 374 (3): 254-62. doi:10.1056/NEJMcp1513724. PMID 26789873. ... Brandão CM, Lima MG, Silva AL, Silva GD, Guerra AA, Acúrcio F (2008). "Treatment of postmenopausal osteoporosis in women: a ...

Haguenauer D, Welch V, Shea B, Tugwell P, Wells G (2000). "Fluoride for treating postmenopausal osteoporosis". The Cochrane ... Fluoride supplementation has been extensively studied for the treatment of postmenopausal osteoporosis. This supplementation ... Reports have claimed that water fluoridation can be linked to the development of osteoporosis and various cancers; however, a ... Osteoporosis International. 19 (3): 257-68. doi:10.1007/s00198-007-0437-6. PMID 17701094. S2CID 25890845. Takahashi R, Ota E, ...

Fluoride supplementation has been extensively studied for the treatment of postmenopausal osteoporosis. This supplementation ... "Fluoride for treating postmenopausal osteoporosis". The Cochrane Database of Systematic Reviews. 2010 (4): CD002825. doi: ... "Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society ... In the higher doses used to treat osteoporosis, plain sodium fluoride can cause pain in the legs and incomplete stress ...

In 2007, the U.S. Food and Drug Administration (FDA) also approved it for the treatment of postmenopausal osteoporosis. ... May 2007). "Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis". The New England Journal of Medicine. 356 ... Vondracek SF (April 2010). "Managing osteoporosis in postmenopausal women". American Journal of Health-System Pharmacy. 67 (7 ... "Biotech PRESS RELEASE: Novartis's Reclast Receives FDA Approval FOR Women With Postmenopausal Osteoporosis" (Press release). ...

Ji, Meng-Xia; Yu, Qi (2015-03-21). "Primary osteoporosis in postmenopausal women". Chronic Diseases and Translational Medicine ... Elderly people with osteoporosis and frailty have a higher risk of hip, vertebra, distal radius and humerus fractures. These ... 700-800 mg of calcium per day is recommended to prevent osteoporosis. Protein supplementation has been shown to have additive ... Endo, Naoto (2016-06-01). "Osteoporosis as a Cause of Locomotive Syndrome: The Influence on Functional Mobility and Activities ...

ISBN 978-1-4511-7861-6. Andrea R. Genazzani (17 January 2006). Postmenopausal Osteoporosis: Hormones & Other Therapies. Taylor ... 243-. ISBN 978-1-84214-311-7. Lobo RA (June 2001). "Androgens in postmenopausal women: production, possible role, and ... osteoporosis, and low sexual desire in women, and to treat breast cancer in women. It is taken by mouth or held in the cheek or ... specifically for osteoporosis, hot flashes, and to increase libido and energy), postpartum breast pain and engorgement, and ...

... is approved in Japan for second-line treatment of postmenopausal osteoporosis. Evidence is restricted to small- ... Iwamoto J (May 2014). "Vitamin K2 therapy for postmenopausal osteoporosis". Nutrients. 6 (5): 1971-80. doi:10.3390/nu6051971. ... mass parameters evaluated by microdensitometry and/or single photon absorptiometry in postmenopausal women with osteoporosis ...

In postmenopausal women with osteoporosis, lasofoxifene at a dose of 0.5 mg per day was associated with reduced risks of ... "Lasofoxifene in postmenopausal women with osteoporosis". The New England Journal of Medicine. 362 (8): 686-96. doi:10.1056/ ... for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene". Clinical Interventions in Aging. 5: 19-29. ... Gennari L (June 2006). "Lasofoxifene: a new type of selective estrogen receptor modulator for the treatment of osteoporosis". ...

... is used in the treatment of menopausal symptoms like hot flashes and vaginal atrophy, postmenopausal osteoporosis, and ... Ettinger B (May 2007). "Tibolone for prevention and treatment of postmenopausal osteoporosis". Maturitas. 57 (1): 35-38. doi: ... Meeta (15 December 2013). Postmenopausal Osteoporosis: Basic and Clinical Concepts. Jaypee Brothers Publishers. pp. 117-. ISBN ... is a medication which is used in menopausal hormone therapy and in the treatment of postmenopausal osteoporosis and ...

August 2002). "Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for ... "Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal ... and osteoporosis.[citation needed] In its entirety, the WHI enrolled more than 160,000 postmenopausal women aged 50-79 years ( ... Among postmenopausal women, cardiovascular disease, cancer, and osteoporosis are the leading causes of morbidity and mortality ...

Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL), Investigators. (August 2012). "A phase 3 trial of the efficacy and ... Paget's disease is not associated with osteoporosis. Although Paget's disease and osteoporosis can occur in the same patient, ... The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial". Journal of Bone and Mineral Research. 27 (8): 1821-1829. ... study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women ...

October 2016). "Romosozumab Treatment in Postmenopausal Women with Osteoporosis". The New England Journal of Medicine. 375 (16 ... Victoria Rees (13 December 2019). "EC approves treatment for severe osteoporosis postmenopausal women". European Pharmaceutical ... and bone strength in a rat model of postmenopausal osteoporosis". Journal of Bone and Mineral Research. 24 (4): 578-88. doi: ... "Modulating Bone Resorption and Bone Formation in Opposite Directions in the Treatment of Postmenopausal Osteoporosis". Drugs. ...

"FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture". U.S. Food and Drug ... October 2016). "Romosozumab Treatment in Postmenopausal Women with Osteoporosis". The New England Journal of Medicine. 375 (16 ... Rees V (13 December 2019). "EC approves treatment for severe osteoporosis postmenopausal women". European Pharmaceutical Review ... Romosozumab, sold under the brand name Evenity, is a medication used to treat osteoporosis. It has been found to decrease the ...

Estrogen therapy in postmenopausal osteoporosis reduces BMAT. Antiresorptive therapies like risedronate or zoledronate also ... "Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women". Osteoporosis International. 19 (9 ... Thus, bone fragility, osteoporosis, and osteoporotic fractures are thought to be linked to mechanisms which promote BMAT ... Duque G, Li W, Adams M, Xu S, Phipps R (May 2011). "Effects of risedronate on bone marrow adipocytes in postmenopausal women". ...

"Long-term treatment with calcitriol in postmenopausal osteoporosis". Metabolism. 39 (4 Suppl 1): 43-9. doi:10.1136/bmj.1.223. ...

In those with postmenopausal osteoporosis denosumab decreases the risk of fractures but increases the risk of infection. A 2013 ... On 2 June 2010, denosumab was approved by the FDA for use in postmenopausal women with risk of osteoporosis under the trade ... Josse R, Khan A, Ngui D, Shapiro M (March 2013). "Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis". ... 2014). "Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis". ...

"Long-term treatment with calcitriol in postmenopausal osteoporosis". Metabolism. 39 (4 Suppl 1): 43-9. doi:10.1136/bmj.1.223. ...

Prevention or treatment of osteoporosis in postmenopausal women. Nandrolone decanoate is approved for this use. Although they ... In low doses as a component of hormone therapy for postmenopausal and transgender women, for instance to increase energy, well- ... specifically for osteoporosis, hot flashes, and to increase libido and energy), postpartum breast pain and engorgement, and ... anabolic ratio are preferred for anemia and osteoporosis, and to reverse protein loss following trauma, surgery, or prolonged ...

FSH may contribute to postmenopausal osteoporosis and cardiovascular disease. If high FSH levels occur during the reproductive ... "Extragonadal Effects of Follicle-Stimulating Hormone on Osteoporosis and Cardiovascular Disease in Women during Menopausal ...

More common in women because of post-menopausal osteoporosis. The Colles fracture is named after Abraham Colles (1773-1843), an ... Risk factors include osteoporosis. The diagnosis may be confirmed via X-rays. The tip of the ulna may also be broken. Treatment ... Originally it was described in elderly and/or post-menopausal women. It usually occurs about three to five centimetres proximal ... Colles fracture is a common fracture in people with osteoporosis, second only to vertebral fractures.[citation needed] ...

... is used in the prevention of postmenopausal osteoporosis. Bazedoxifene is marketed both alone and in combination ... of postmenopausal osteoporosis. It is also being studied for possible treatment of breast cancer and pancreatic cancer. ... "Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors". Duke University Medical Center. June 15, 2013 ... for the treatment of menopausal osteoporosis and the treatment of moderate to severe hot flushes. This is the first approved ...

... a 68-year-old female with advanced postmenopausal osteoporosis; and a healthy 24-year-old medical student without any clinical ... resulting in weaker bones that are more prone to pathologic fracture and osteoporosis. However, deficiency is rare in adults, ...

Lindsay R, Cosman F (January 2007). "Pathogenesis of osteoporosis.". Treatment of the Postmenopausal Woman (3rd ed.). pp. 323- ... Bone resorption rates are much higher in post-menopausal older women due to estrogen deficiency related with menopause. Common ... Some diseases with symptoms of decreased bone density are osteoporosis, and rickets. Some people who experience increased bone ... especially osteopenia and osteoporosis, endocrine diseases, rheumatic disorders, and other cases, as well as in patients with ...

"Abaloparatide May Help Prevent Fractures in Postmenopausal Women with Osteoporosis". Newswise. Retrieved 2016-04-03. "Felicia ... in the treatment of severe osteoporosis. Her research has focused on the causes of osteoporosis and how the female hormone ... She is an osteoporosis specialist and was a clinical scientist at Helen Hayes Hospital in West Haverstraw, New York. Dr. Cosman ... She also is studying experimental treatments for osteoporosis, including parathyroid hormone, and the causes of stress ...

... and treatment of postmenopausal osteoporosis and breast cancer prevention in high-risk postmenopausal women with osteoporosis. ... Bazedoxifene is used as treatment for osteoporosis in postmenopausal women at increased risk of fracture. It has been shown to ... Bazedoxifene is also used in the prevention of postmenopausal osteoporosis. The search for a potent SERM with bone efficacy and ... In Europe, bazedoxifene is indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fracture ...

... maintain bone density and to prevent osteoporosis in postmenopausal women. It is not used to treat osteoporosis. It slows down ... March 2001). "Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial". JAMA. 285 (11): 1482 ... A clinical trial reported in 2001 that it was not effective in prevention or treatment of osteoporosis. A double-blind study ... as the drug does not bind to or activate the estrogen receptor and shows no estrogenic effects in postmenopausal women. The ...

"Labisia pumila regulates bone-related genes expressions in postmenopausal osteoporosis model". BMC Complementary and ... and relieving postmenopausal discomfort. Currently accepted species include: Labisia acuta Ridl. Labisia alata N.E.Br. Labisia ...

Blueberry prevents bone loss in ovariectomized rat model of postmenopausal osteoporosis. J Nutr Bioch, 19(10):694-9, 2008. ... 2010 Jul 8. One year soy protein supplementation does not improve lipid profile in postmenopausal women. Menopause 2010 Mar 3. ... Flaxseed Reduces LDL- and Total-Cholesterol Concentrations in Native American Postmenopausal Women. J Women's Health Gend, 17: ... His current research emphasis is women's health including cardiovascular health, osteoporosis, and osteoarthritis. Arjmandi ...

In the higher doses used to treat osteoporosis, sodium fluoride can cause pain in the legs and incomplete stress fractures when ... Haguenauer, D; Welch, V; Shea, B; Tugwell, P; Adachi, JD; Wells, G (2000). "Fluoride for the treatment of postmenopausal ... Murray TM, Ste-Marie LG (1996). "Prevention and management of osteoporosis: consensus statements from the Scientific Advisory ... 7. Fluoride therapy for osteoporosis". CMAJ. 155 (7): 949-54. PMC 1335460. PMID 8837545. National Health and Medical Research ...